Skip to content

Comparative clinical study of pathyadi churn and erand tail in Aamvat (joint related disorder)

A Comparative Clinical Evaluation of Pathyadi Churna and Erand Tail (Castor Oil) in the Management of Amavat (Rheumatoid Arthritis) with Special References to GUT MICROBIOME - NIL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063710
Enrollment
90
Registered
2024-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

None listed

Sponsors

Department of Kayachikitsa Faculty of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate for this trial. Diagnosed cases of Amavata based on symptoms and signs described in Madava Nidana & ACR-EULAR 2010. Sero positive &Sero negative both cases are included.

Exclusion criteria

Exclusion criteria: Not willing patients. Patients with short history of less than a year. Patients having severe deformities. Patients of Gouty Arthritis, Septic Arthritis, Osteoarthritis, Ankylosing Spondylitis. HIV, Tuberculosis, Hypertension, D.M., & other systemic problems. ? Pregnant & lactating women ? Patients with major complications are like pleural effusion, ascites also excluded.

Design outcomes

Primary

MeasureTime frame
A) Pain B) TENDERNESS C) MORNING STIFFNESS D) SWELLING OVER JOINTS E) FUNCTIONAL ASSESSMENT: F) WALKING TIME G) GRIP POWER & PRESSING POWER H) RANGE OF MOTIONTimepoint: 90 days study with follow-up of every 30 days

Secondary

MeasureTime frame
a. Laboratory Investigations- b. Hematological—Hb%, TLC, DLC, ESR c. Biochemical—LFT, RFT, Lipid Profile, Blood Sugar. d. Anti CCP antibodies(immunopathological marker) e. RA factor Quantitative, CRP Quantitative f. ASO –titreTimepoint: 90 days study with follow-up of every 30 days

Countries

India

Contacts

Public ContactDr Narendra Kumar Gautam

Banaras Hindu University

singhopbhu@gmail.com9415818732

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026